Showing results (1181-1190 of 7,013) with videos related to

Sort By:
Pageof 702
Lung Cancer (Amsterdam, Netherlands)|October 31, 2006
Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): results of a prospective randomized studyEmilio Esteban, Jose-Luis de Sande, Noemi Villanueva, et al.
Lung Cancer (Amsterdam, Netherlands)|October 25, 2006
Malignant pleural mesothelioma: a new standard of careRolf A Stahel
Lung Cancer (Amsterdam, Netherlands)|December 17, 2008
How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study GroupJ Nyman, S Friesland, A Hallqvist, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2008
Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trialVittorio Gebbia, Cesare Gridelli, Claudio Verusio, et al.
Lung Cancer (Amsterdam, Netherlands)|March 6, 2009
Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinomaRui Wang, Jian Geng, Jing-hua Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2009
Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patientsEleni M Karapanagiotou, Aristidis Polyzos, Kalliopi D Dilana, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2009
Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experienceRavi J Menezes, Heidi C Roberts, Narinder S Paul, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2009
Reliability of chromogenic in situ hybridization for epidermal growth factor receptor gene copy number detection in non-small-cell lung carcinomas: a comparison with fluorescence in situ hybridization studySeol Bong Yoo, Hyun Ju Lee, Jung Ok Park, et al.
Lung Cancer (Amsterdam, Netherlands)|March 24, 2009
Impact and interactions between smoking and traditional prognostic factors in lung cancer progressionNancy L Guo, Kursad Tosun, Kimberly Horn
Lung Cancer (Amsterdam, Netherlands)|March 24, 2009
Polymorphisms of the ribonucleotide reductase M1 gene and sensitivity to platin-based chemotherapy in non-small cell lung cancerJi-Feng Feng, Jian-Zhong Wu, Sai-Nan Hu, et al.
Pageof 702